Feriel Azibani

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3.

Journal: mAbs
Published: May 21, 2026

Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.

Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.

Journal: mAbs
Published: May 21, 2026

Cardiogenic shock supported with VA-ECMO: Association between cDPP3 concentrations and outcomes in a post hoc analysis of the ADRECMO cohort.

Cardiogenic shock supported with VA-ECMO: Association between cDPP3 concentrations and outcomes in a post hoc analysis of the ADRECMO cohort.

Journal: Journal of cardiac failure
Published: March 02, 2026

Risk of Posttransplant Cyclophosphamide-related Cardiotoxicity in Allogeneic Stem Cell Transplantation.

Risk of Posttransplant Cyclophosphamide-related Cardiotoxicity in Allogeneic Stem Cell Transplantation.

Journal: The Canadian journal of cardiology
Published: January 26, 2026

cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies.

cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies.

Journal: ESC heart failure
Published: November 25, 2025

Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies.

Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies.

Journal: ESC heart failure
Published: November 25, 2025

Cardiac biomarkers response under angiotensin receptor-neprilysin inhibitor: a sub-analysis of the NATRIUM-HF study.

Cardiac biomarkers response under angiotensin receptor-neprilysin inhibitor: a sub-analysis of the NATRIUM-HF study.

Journal: ESC heart failure
Published: November 06, 2025

Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial.

Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial.

Journal: Critical care (London, England)
Published: September 23, 2025

Effects of septic shock vasopressors on the fitness of Escherichia coli.

Effects of septic shock vasopressors on the fitness of Escherichia coli.

Journal: Scientific reports
Published: September 19, 2025

Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress.

Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress.

Journal: iScience
Published: September 16, 2025

Targeting high circulating dipeptidyl peptidase 3 in circulatory failure.

Targeting high circulating dipeptidyl peptidase 3 in circulatory failure.

Journal: Critical care (London, England)
Published: June 15, 2025

Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients.

Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients.

Journal: European journal of preventive cardiology
Published: May 23, 2025
Showing 1-12 of 65

Last Updated: 09/26/2026